BMC Neurology

Table 2 Clinical information (n = 26; IVIG intravenous immunoglobulins, CIDP chronic inflammatory demyelinating polyneuropathy, INCAT Inflammatory Neuropathy Cause and Treatment, GS glucocorticosteroids)

From: Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP

		typical	atypical	p-values atypical vs. typical
Sex	male	3/9 (33%)	14/17 (82%)	0.013
	female	6/9 (66%)	3/17 (18%)
Age (years)	mean	61.0	57.2	0.512
	range	32-78	33-74
Previous treatment	None	3/9 (33%)	9/17 (53%)	0.429^a
	IVIG	4/9 (44%)	6/17 (35%)	0.652^a
	Steroid	2/9 (22%)	2/17 (12%)	0.547^a
Time since diagnosis	mean	4.1	4.2	0.860
(years)	range	1-8	1-7
INCAT	mean	3.2	2.3	0.045
	Range	<1-8	<1-7
Disease activity	range	1-5	1-3
	active-unstable	6/9 (66%)	14/17 (82%)	1.000^b
	active-stable	1/9 (11%)	0/17 (0%)	0.333^b
	in remission	2/9 (22%)	3/17 (18%)	1.000^b
Therapy response	responder	9/9 (100%)	8/17 (47%)	0.022
	non-responder	0/9 (0%)	9/17 (53%)

Fishers exact test for sex, previous treatment, disease activity and therapy response
^acompared versus treatment naïve patients
^bcompared versus remission state; unpaired t-test for age and INCAT score; Mann-Whitney test for time since diagnosis

Back to article page

ISSN: 1471-2377

Contact us

General enquiries: journalsubmissions@springernature.com